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ABSTRACT

Background
The ability to prevent tumor repopulation after anticancer treatments has been a
significant barrier to reducing morbidity and mortality of malignant tumors.
Chemotherapeutic agents induce the death of rapidly dividing cells and dying cells can
produce mitogenic cues that stimulate proliferation and promote repair. Whether these
regenerative mechanisms are co-opted by tumor cells after cancer treatment is not well
understood. Our data show that small membrane-bound vesicles generated during cell
death (called apoptotic extracellular vesicles, or AEVs) serve as vehicles for the transfer
of genetic information and the activation of signaling pathways that promote cell
proliferation. We have identified the known mitogen and cytokine macrophage
migration inhibitor factor (MIF) as enriched on apoptotic extracellular vesicles derived
from epithelial stem cells in zebrafish. The goal of this project is to test if apoptotic
extracellular vesicles from human breast cancer cells (bcAEVs) use MIF to evade the
immune system and stimulate proliferation.
Methods
Apoptotic extracellular vesicles from MDA-MB231 breast cancer cells after exposure to
chemotherapeutic agents were isolated by differential centrifugation for downstream
studies. Immunogold labeling with transmission electron microscopy was used to
determine the localization of the mitogenic and immunogenic protein Macrophage
Migration Inhibitory Factor (MIF). Isolated bcAEVs were fluorescently labeled and
injected into larval zebrafish where confocal microscopy was used to track interaction
with macrophages expressing EGFP. Cell proliferation was also assessed using a BrdU
incorporation assay. Chemical inhibitors against MIF were used to perturb the activity of
specific breast cancer derived apoptotic bodies to assay for effects on proliferation.
Results
Foci of MIF were detected on the surface of the apoptotic extracellular vesicles (AEVs)
purified from human breast cancer cells. Fluorescently labeled AEVs were tracked after
injection into the zebrafish and were observed interacting with macrophages, providing a
novel assay for probing interactions with the immune system in vivo. We observed an in
increase in proliferation in larvae injected with bcAEVs, however before examination of
MIF inhibition could be performed, further adjustments of drug controls timing and
concentration are needed.
Conclusion
Here we show that the mitogenic and immunogenic protein MIF is present on the
surface of bcAEVs and characterize the immunogenic and proliferative responses after
introduction into zebrafish larvae. Future studies will inhibit MIF after delivery of the
bcAEVs to the zebrafish larvae, with the goal of providing new insights into molecular
pathways that can be leveraged against cancer by preventing the unwanted addition of
new cells.
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METHODS AND RESULTS

bcAEV Isolation and injection into zebrafish

RESULTS CONTINUED
bcAEVs Stimulate Cell Proliferation

Fig.1 bcAEVs Isolation using Differential centrifugation and zebrafish injection performed. a MDA-231 human breast cancer cells were treated with cisplatin and UV treatment
resembling chemotherapeutic agents. Breast cancer AEVs were isolated using differential centrifugation for downstream studies and injected into developing zebrafish. b Injection site
is found at the Duct of Cuvier. Zebrafish lines used were Mpeg GFP.

MIF is located on the surface of bcAEVs

Fig. 2 The Mitogenic and Immunogenic protein MIF is present on the surface of bcAEVs. a Immunogold labeling with transmission electron microscopy was used to determine the
localization of the mitogenic and immunogenic protein Macrophage Migration Inhibitory Factor (MIF) on purified apoptotic extracellular vesicles from human breast cancer cells. b The
concentration and size of bcAEVs were quantified using tunable pulse resistance sensing with the qNano Instruments

In vivo tracking of bcAEVs and interaction with macrophages

Prominent Stimulation of cell proliferation can be observed in bcAEVs injected
zebrafish larvae condition. BrdU Incorporation Assay was performed to examine
dividing cells. Four conditions were analyzed without 4IPP treatments.

CONCLUSION

Small membrane-bound vesicles generated during cell death are known as apoptotic bodies.

• The Mitogenic and Immunogenic protein MIF is
present on the surface of bcAEVs.
• We observed an in increase in proliferation in larvae
injected with bcAEVs.
• bcAEVs and Macrophages interact with each other.
Macrophages engulf bcAEVs.
• AEVs leave the Vasculature to possibly contact other
cell types.

The Fluorescent intensity of AEVs decreases overtime possibly indicating clearance. Fluorescently labeled bcAEVs were injected into developing zebrafish 2pdf and imagined at
2hpi. Injected Zebrafish larvae continued to be imaged over time under homeostatic conditions until Larvae reached 5dpf. Fluorescent intensity of AEVs decreases in the circulation
within the tail, while fluorescent intensity of AEVs injected in the yolk remains constant. This indicates possible AEV clearance by macrophages.

AKNOWLEDGEMENTS
We thank Kenneth Dunner Jr. at the UT MD Anderson High Resolution Electron
Microscopy Facility for assistance with the electron microscopy data. This work
was supported by the Cancer Prevention Institute of Texas, RR14007, and the
National Institutes of General Medical Sciences, R01GM124043, to GTE.

The Number of Macrophages around the Fluorescently labeled bcAEVs diminishes 24hpi with treatment of MIF inhibitor. Fluorescently labeled Macrophages were tracked
frame by frame using Imaris. Each colored track represents macrophage movement The color of the tracks represents when the macrophages were present.

bcAEVs contain proteins that contribute to cell various cell functions and processes.
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